首页 > 最新文献

Pneumologie最新文献

英文 中文
[Outpatient care in pulmonology - a scientific analysis and a position paper of the German Society of Respiratory Medicine (DGP)]. [肺科门诊护理--德国呼吸医学会(DGP)的科学分析和立场文件]。
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-20 DOI: 10.1055/a-2279-7787
Kaid Darwiche, Winfried Randerath, Ralf-Harto Hübner, Markus Rathmayer, Melanie Tiefgraber, Volkmar Borass, Anne Piening, Lars Hagmeyer, Juergen Hetzel, Ralf Eberhardt, Wolfgang Gesierich, Markus Unnewehr, Sebastian Boeing, Michael Wilke, Felix Herth, Torsten Bauer

Introduction:  The ambulantization of patient care that were previously provided as inpatient service is one of the goals of the current reform in the German healthcare system. In pulmonology, this particularly applies to endoscopic procedures. However, the real costs of endoscopic services, which form the basis for the calculation of a future so called hybrid DRG or in the AOP catalog, are unclear.

Methods:  After selection of use cases including endoscopic procedures which can be performed on an outpatient basis by a committee of experts the appropriate DRGs were identified from the § 21-KHEntgG data for 2022 published by the Institute for the Hospital Remuneration System (InEK). The costs were calculated from the respective InEK cost matrix added by the calculated material costs.

Results:  The use cases suitable for outpatient treatment were systematic endobronchial ultrasound (EBUS) with transbronchial needle aspiration (calculated costs € 2,175.60 without or € 3,315.60 including PET/CT), navigation-assisted bronchoscopy for peripheral lesions (depending on the methodology € 2,870.23 to €4,120.23) and diagnostic (flexible) bronchoscopy (€ 1,121.02).

Conclusion:  Outpatient treatment of endoscopic procedures that were previously performed inpatient is possible and necessary, and the costs calculated in this publication can form a reliable basis for appropriate reimbursement. Together with a structural quality that has been transformed to outpatient service and cross-sector cooperation, continued high-quality care for pneumological patients can be ensured.

简介德国医疗系统目前的改革目标之一,是将以前作为住院服务提供的病人护理工作救护车化。在肺科,这尤其适用于内窥镜手术。然而,作为未来所谓混合 DRG 或 AOP 目录计算基础的内窥镜服务的实际成本并不明确:方法:由专家委员会对包括可在门诊进行的内窥镜手术在内的使用病例进行筛选后,从医院薪酬系统研究所(InEK)公布的 2022 年§ 21-KHEntgG 数据中确定了相应的 DRGs。成本根据 InEK 的成本矩阵计算,并加上计算得出的材料成本:结果:适合门诊治疗的病例有系统支气管内超声(EBUS)和经支气管针吸术(不含 PET/CT 的计算费用为 2,175.60 欧元,含 PET/CT 的计算费用为 3,315.60 欧元)、针对周边病变的导航辅助支气管镜检查(视方法而定,为 2,870.23 欧元至 4,120.23 欧元)和诊断性(柔性)支气管镜检查(1,121.02 欧元):本出版物计算出的费用可作为适当报销的可靠依据。再加上已转变为门诊服务的结构质量和跨部门合作,可以确保为肺科病人提供持续的高质量医疗服务。
{"title":"[Outpatient care in pulmonology - a scientific analysis and a position paper of the German Society of Respiratory Medicine (DGP)].","authors":"Kaid Darwiche, Winfried Randerath, Ralf-Harto Hübner, Markus Rathmayer, Melanie Tiefgraber, Volkmar Borass, Anne Piening, Lars Hagmeyer, Juergen Hetzel, Ralf Eberhardt, Wolfgang Gesierich, Markus Unnewehr, Sebastian Boeing, Michael Wilke, Felix Herth, Torsten Bauer","doi":"10.1055/a-2279-7787","DOIUrl":"10.1055/a-2279-7787","url":null,"abstract":"<p><strong>Introduction: </strong> The ambulantization of patient care that were previously provided as inpatient service is one of the goals of the current reform in the German healthcare system. In pulmonology, this particularly applies to endoscopic procedures. However, the real costs of endoscopic services, which form the basis for the calculation of a future so called hybrid DRG or in the AOP catalog, are unclear.</p><p><strong>Methods: </strong> After selection of use cases including endoscopic procedures which can be performed on an outpatient basis by a committee of experts the appropriate DRGs were identified from the § 21-KHEntgG data for 2022 published by the Institute for the Hospital Remuneration System (InEK). The costs were calculated from the respective InEK cost matrix added by the calculated material costs.</p><p><strong>Results: </strong> The use cases suitable for outpatient treatment were systematic endobronchial ultrasound (EBUS) with transbronchial needle aspiration (calculated costs € 2,175.60 without or € 3,315.60 including PET/CT), navigation-assisted bronchoscopy for peripheral lesions (depending on the methodology € 2,870.23 to €4,120.23) and diagnostic (flexible) bronchoscopy (€ 1,121.02).</p><p><strong>Conclusion: </strong> Outpatient treatment of endoscopic procedures that were previously performed inpatient is possible and necessary, and the costs calculated in this publication can form a reliable basis for appropriate reimbursement. Together with a structural quality that has been transformed to outpatient service and cross-sector cooperation, continued high-quality care for pneumological patients can be ensured.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kommentar zu „Atezolizumab als Erstlinientherapie bei älteren Patienten mit NSCLC“ 关于 "将阿特珠单抗作为老年 NSCLC 患者的一线疗法 "的评论
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 DOI: 10.1055/a-2253-3857
{"title":"Kommentar zu „Atezolizumab als Erstlinientherapie bei älteren Patienten mit NSCLC“","authors":"","doi":"10.1055/a-2253-3857","DOIUrl":"https://doi.org/10.1055/a-2253-3857","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights vom DGP-Kongress 2024 aus Sicht der YoungDGP 从青年总干事的角度看 2024 年总干事代表大会的亮点
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 DOI: 10.1055/a-2298-6312
Katharina Buschulte, Erik Büscher, Klaas Franzen, Armin Frille, Espen Groth, J. Hoffmann, Andreas Knaack, Johannes Krönig, Christoph Lederer, Gabriela Leuschner, Eva Pappe, Nina Sicker, Finn Wilkens, Christoph Fisser
{"title":"Highlights vom DGP-Kongress 2024 aus Sicht der YoungDGP","authors":"Katharina Buschulte, Erik Büscher, Klaas Franzen, Armin Frille, Espen Groth, J. Hoffmann, Andreas Knaack, Johannes Krönig, Christoph Lederer, Gabriela Leuschner, Eva Pappe, Nina Sicker, Finn Wilkens, Christoph Fisser","doi":"10.1055/a-2298-6312","DOIUrl":"https://doi.org/10.1055/a-2298-6312","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141052843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Medical societies in Germany call for a ban on flavors in e-cigarettes - A Position Paper of the German Respiratory Society (DGP) in cooperation with other professional associations and organizations]. [德国医学协会呼吁禁止在电子烟中使用香精--德国呼吸协会(DGP)与其他专业协会和组织合作撰写的立场文件]。
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 Epub Date: 2024-03-19 DOI: 10.1055/a-2282-9908
Alexander Rupp, Natascha Sommer, Stefan Andreas, Wulf Pankow, Reiner Hanewinkel, Harm Wienbergen, Anil Batra, Tilman Sauerbruch, Peter Kardos, Sabina Ulbricht, Folke Brinkmann, Robert Scheubel, Claus Vogelmeier, Wolfram Windisch

E-cigarettes are primarily used by teenagers and young adults. Flavors in e-cigarettes increase their attractiveness and encourage young people and adults to start using them. This exposes young people in particular to the risk of nicotine addiction and various toxic substances from the aerosol of e-cigarettes. There are indications that various flavors in e-cigarettes are harmful to health, although toxicological studies are still lacking for the majority of flavors. There is a need for independent scientific investigations in this area. The scientific societies involved are calling for a ban on flavors in e-cigarettes, a ban on disposable e-cigarettes, effective regulation of the sale of e-cigarettes and effective control and implementation of the provisions for the protection of minors.

电子烟的主要使用者是青少年和年轻人。电子烟中的香料增加了电子烟的吸引力,鼓励年轻人和成年人开始使用电子烟。这尤其使年轻人面临尼古丁上瘾的风险和电子烟气雾中的各种有毒物质。有迹象表明,电子烟中的各种口味对健康有害,尽管对大多数口味仍缺乏毒理学研究。有必要在这一领域开展独立的科学调查。相关科学协会呼吁禁止使用电子烟中的香精,禁止使用一次性电子烟,对电子烟的销售进行有效监管,并有效控制和执行保护未成年人的规定。
{"title":"[Medical societies in Germany call for a ban on flavors in e-cigarettes - A Position Paper of the German Respiratory Society (DGP) in cooperation with other professional associations and organizations].","authors":"Alexander Rupp, Natascha Sommer, Stefan Andreas, Wulf Pankow, Reiner Hanewinkel, Harm Wienbergen, Anil Batra, Tilman Sauerbruch, Peter Kardos, Sabina Ulbricht, Folke Brinkmann, Robert Scheubel, Claus Vogelmeier, Wolfram Windisch","doi":"10.1055/a-2282-9908","DOIUrl":"10.1055/a-2282-9908","url":null,"abstract":"<p><p>E-cigarettes are primarily used by teenagers and young adults. Flavors in e-cigarettes increase their attractiveness and encourage young people and adults to start using them. This exposes young people in particular to the risk of nicotine addiction and various toxic substances from the aerosol of e-cigarettes. There are indications that various flavors in e-cigarettes are harmful to health, although toxicological studies are still lacking for the majority of flavors. There is a need for independent scientific investigations in this area. The scientific societies involved are calling for a ban on flavors in e-cigarettes, a ban on disposable e-cigarettes, effective regulation of the sale of e-cigarettes and effective control and implementation of the provisions for the protection of minors.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140176113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[COVID-19 in the intensive care unit]. [重症监护室中的 COVID-19]。
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 Epub Date: 2024-05-17 DOI: 10.1055/a-1854-2693
André P Becker, Sebastian Mang, Torben Rixecker, Philipp M Lepper

The acute respiratory failure as well as ARDS (acute respiratory distress syndrome) have challenged clinicians since the initial description over 50 years ago. Various causes can lead to ARDS and therapeutic approaches for ARDS/ARF are limited to the support or replacement of organ functions and the prevention of therapy-induced consequences. In recent years, triggered by the SARS-CoV-2 pathogen, numerous cases of acute lung failure (C-ARDS) have emerged. The pathophysiological processes of classical ARDS and C-ARDS are essentially similar. In their final stages of inflammation, both lead to a disruption of the blood-air barrier. Treatment strategies for C-ARDS, like classical ARDS, focus on supporting or replacing organ functions and preventing consequential damage. This article summarizes the treatment strategies in the intensive care unit.

自 50 多年前首次描述急性呼吸衰竭和 ARDS(急性呼吸窘迫综合征)以来,它一直是临床医生面临的挑战。导致 ARDS 的原因多种多样,而 ARDS/ARF 的治疗方法仅限于支持或替代器官功能以及预防治疗引起的后果。近年来,由 SARS-CoV-2 病原体引发的急性肺不张(C-ARDS)病例层出不穷。传统 ARDS 和 C-ARDS 的病理生理过程基本相似。在炎症的最后阶段,两者都会导致血气屏障的破坏。与传统的 ARDS 一样,C-ARDS 的治疗策略也侧重于支持或替代器官功能以及预防相应的损伤。本文总结了重症监护病房的治疗策略。
{"title":"[COVID-19 in the intensive care unit].","authors":"André P Becker, Sebastian Mang, Torben Rixecker, Philipp M Lepper","doi":"10.1055/a-1854-2693","DOIUrl":"https://doi.org/10.1055/a-1854-2693","url":null,"abstract":"<p><p>The acute respiratory failure as well as ARDS (acute respiratory distress syndrome) have challenged clinicians since the initial description over 50 years ago. Various causes can lead to ARDS and therapeutic approaches for ARDS/ARF are limited to the support or replacement of organ functions and the prevention of therapy-induced consequences. In recent years, triggered by the SARS-CoV-2 pathogen, numerous cases of acute lung failure (C-ARDS) have emerged. The pathophysiological processes of classical ARDS and C-ARDS are essentially similar. In their final stages of inflammation, both lead to a disruption of the blood-air barrier. Treatment strategies for C-ARDS, like classical ARDS, focus on supporting or replacing organ functions and preventing consequential damage. This article summarizes the treatment strategies in the intensive care unit.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Palliative aspects in pulmonary oncology]. [肺部肿瘤学的姑息治疗]。
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 Epub Date: 2023-12-11 DOI: 10.1055/a-2206-5602
David Heigener, Sandra Delis

Palliative medicine is an essential part in the treatment of patients with advanced or metastatic NSCLC. A structured palliative approach beginning from diagnoses improves quality of life and maybe even prolong survival. Besides symptom control, the disease trajectory and prognosis should regularly be re-evaluated and discussed with the patient and his loved ones.

姑息治疗是晚期或转移性非小细胞肺癌患者治疗的重要组成部分。从诊断开始就采取有条理的姑息治疗方法可以提高患者的生活质量,甚至延长生存期。除了控制症状外,还应定期重新评估疾病的发展轨迹和预后,并与患者及其亲人进行讨论。
{"title":"[Palliative aspects in pulmonary oncology].","authors":"David Heigener, Sandra Delis","doi":"10.1055/a-2206-5602","DOIUrl":"10.1055/a-2206-5602","url":null,"abstract":"<p><p>Palliative medicine is an essential part in the treatment of patients with advanced or metastatic NSCLC. A structured palliative approach beginning from diagnoses improves quality of life and maybe even prolong survival. Besides symptom control, the disease trajectory and prognosis should regularly be re-evaluated and discussed with the patient and his loved ones.</p>","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138808865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab hilft bei COPD mit Typ-2-Inflammation 杜匹单抗有助于治疗伴有 2 型炎症的慢性阻塞性肺病
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 DOI: 10.1055/a-2238-5294
{"title":"Dupilumab hilft bei COPD mit Typ-2-Inflammation","authors":"","doi":"10.1055/a-2238-5294","DOIUrl":"https://doi.org/10.1055/a-2238-5294","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141051765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Akutes Atemnotsyndrom (ARDS): Bessere Diagnostik durch Lungenultraschall 急性呼吸窘迫综合征(ARDS):肺部超声诊断更有效
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 DOI: 10.1055/a-2196-8717
{"title":"Akutes Atemnotsyndrom (ARDS): Bessere Diagnostik durch Lungenultraschall","authors":"","doi":"10.1055/a-2196-8717","DOIUrl":"https://doi.org/10.1055/a-2196-8717","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141028351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geringe Diagnostik-Ausbeute durch elektromagnetische Navigationsbronchoskopie 电磁导航支气管镜导致诊断率低
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 DOI: 10.1055/a-2196-8692
{"title":"Geringe Diagnostik-Ausbeute durch elektromagnetische Navigationsbronchoskopie","authors":"","doi":"10.1055/a-2196-8692","DOIUrl":"https://doi.org/10.1055/a-2196-8692","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141028028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primärer Spontanpneumothorax: Aspiration und Thoraxdrainage im Vergleich 原发性自发性气胸:抽吸与胸腔引流的比较
IF 1.2 Q3 Medicine Pub Date : 2024-05-01 DOI: 10.1055/a-2205-3743
{"title":"Primärer Spontanpneumothorax: Aspiration und Thoraxdrainage im Vergleich","authors":"","doi":"10.1055/a-2205-3743","DOIUrl":"https://doi.org/10.1055/a-2205-3743","url":null,"abstract":"","PeriodicalId":20197,"journal":{"name":"Pneumologie","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141039602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pneumologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1